Zoster Vaccines Recombinant

$50,000.00

The preferred shingles vaccine is Shingrix, a non-live, recombinant vaccine that is over 90% effective at preventing shingles and postherpetic neuralgia (chronic nerve pain).

The preferred shingles vaccine is Shingrix, a non-live, recombinant vaccine that is over 90% effective at preventing shingles and postherpetic neuralgia (chronic nerve pain).